COc1cc(NC(=O)CSc2nc(=O)n(CCN3CCOCC3)c3c2CCCC3)cc(OC)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?